Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Positive trial results of Janssen's sabeluzole in obstructive sleep apnea patients

July 19, 1996

5-HT1-like receptor agonists as migraine treatment from Merck & Co.

July 19, 1996

BTG-2403: representative opioid analgesic

July 19, 1996

Glaxo Wellcome's Ultiva receives FDA approval

July 19, 1996

NOS inhibitors from Merck & Co.

July 12, 1996

TNF research findings

July 12, 1996

Muscarinic receptor ligand selected for further study

July 12, 1996

First demonstration of cellular mechanism of human oral tolerance

July 12, 1996

First approval of SmithKline Beecham's ReQuip in U.K.

July 12, 1996

Lundbeck's Serdolect reaches first market

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...